Hegseth announces troop testosterone screening and hormone replacement therapy option

Defense Secretary Pete Hegseth announced a new military policy under which service members would be tested for low testosterone and, if found to have it, be offered hormone replacement therapy, according to a report by PBS NewsHour on July 15, 2026. The announcement links the screening and treatment to concerns about troops’ health and performance, and it follows growing public attention to testosterone as a health and fitness intervention.

PBS NewsHour reported that the policy announcement is occurring amid broader public promotion of testosterone-related claims by influencers and proponents associated with Robert F. Kennedy’s “Make America Healthy Again” movement. The report said that while some supporters describe testosterone as a way to look younger, build muscle, and sharpen mental focus, those uses are not accepted by most medical experts.

In its reporting, PBS NewsHour contrasted Hegseth’s announced approach with the medical community’s more limited acceptance of testosterone therapy to treat specific clinical conditions, rather than using it for appearance or general enhancement goals. The report described the public debate as centered not only on whether testosterone testing should occur, but also on what outcomes therapy is intended to address.

The announcement raises practical questions about how the military would apply screening criteria, what clinical thresholds would trigger any offer of treatment, and how consent and medical oversight would work across different branches of the armed forces. While Hegseth’s statement establishes the general direction of the policy, the PBS report did not provide additional publicly detailed protocols in the summary used for this account.

The policy is also likely to face scrutiny over consistency with established medical practice and safeguards, particularly because the reported discussion around testosterone includes claims that go beyond typical medically endorsed indications. In institutional settings such as the military, the stakes include not only individual health outcomes but also administrative handling of medical records and uniform standards for who qualifies for any therapy.

As of publication, PBS NewsHour had not indicated that any court ruling or formal rulemaking process had already been completed for the policy described by Hegseth, and the report did not provide an implementation timetable. Service members and advocates may seek clarification on whether participation is tied to symptoms or test results, and what medical monitoring would accompany any therapy offered under the new program.